• Coronavirus Hotline: 1-855-600-3453
  • newmexico.gov
  • nmhealth.org
  • cv.nmhealth.org
NMDOH - CV Modeling
  • Modeling
    • Modeling Updates
  • Reopening Gating Criteria
    • Spread of COVID-19
    • Testing Capacity
    • Contact Tracing and Isolation Capacity
    • Healthcare System Capacity
  • Medical Advisory Team
    • MAT Resources
    • Healthcare Workforce Expansion & Protections
    • Contact the MAT
Select Page

Out-of-hospital infusion services for COVID-19 patients

by alexcastillo | Dec 24, 2020 | MAT Resources

The Medical Advisory Team updates its recommendation regarding out-of-hospital infusion services to manage the risk of infusion reactions in patients treated with intravenous therapies for COVID-19 infection: Personnel providing infusion therapy for COVID-19 should...

Moderna mRNA-1273 COVID-19 vaccine recommendation for New Mexicans

by alexcastillo | Dec 21, 2020 | MAT Resources

The Medical Advisory Team (MAT) Vaccine Safety and Efficacy Workgroup has reviewed the relevant documents related to the Moderna mRNA-1273 vaccine as provided by the manufacturer, the U.S. Food and Drug Administration (FDA), and the U.S. Centers for Disease Control...

Pfizer-BioNTech COVID-19 vaccine recommendation for New Mexicans

by alexcastillo | Dec 18, 2020 | MAT Resources

The Medical Advisory Team (MAT) Vaccine Safety and Efficacy Work group has revised its recommendation to include additional guidance on the management of vaccine supply, including the full use of multi-dose vial contents that may contain more than 5 doses per vial....

Baricitinib (Olumiant) treatment for COVID-19 patients in NM

by alexcastillo | Dec 16, 2020 | MAT Resources

Baricitinib should be consider for use by healthcare providers, in combination with remdesivir (Veklury), to treat suspected or laboratory confirmed COVID-19 in hospitalized adults and pediatric patients 2 years of age or older requiring supplemental oxygen, invasive...

Recent Posts

  • Out-of-hospital infusion services for COVID-19 patients
  • Moderna mRNA-1273 COVID-19 vaccine recommendation for New Mexicans
  • Pfizer-BioNTech COVID-19 vaccine recommendation for New Mexicans
  • Baricitinib (Olumiant) treatment for COVID-19 patients in NM
  • REGN-COV2 treatment for COVID-19 patients in NM

Tags

Behavioral Health Children & Youth Clinical Care Drugs & Therapeutics Nursing Facilities/Long-term Care Personal Protective Equipment (PPE) Public Health Regional Care Coordination Reopening Healthcare Testing Vaccine Workforce

Archives

  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020

Categories

  • MAT Resources

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • Facebook
  • Twitter
  • Instagram

Designed by Elegant Themes | Powered by WordPress